Exo Therapeutics

Exo Therapeutics

Latest funding
$78,000,000
Venture capital (Series B) - 2021
CRV Novartis Venture Fund Nextech Invest +5
Team Size
1–10
Employees
$78,000,000 Venture capital (Series B)
MedCity News

Exo Therapeutics adds $78M as cancer, inflammation drugs march toward clinic